Business Context and Reporting Period
This Form 8-K Current Report was filed by A.I. Software, Inc. (Nevada) on May 5, 2003, reporting an event that occurred on the same date. The registrant is headquartered in Vancouver, British Columbia, Canada.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a strategic corporate development rather than financial performance results.
Material Changes
The primary material change reported is the execution of an agreement with the Weizmann Institute of Science and Technion-Israel Institute of Technology. Key details include:
- Acquisition of an exclusive license for stem cell expansion technology.
- Consideration involves cash payments and future royalties.
- The technology is intended to develop a process to assist with bone marrow transplants.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the licensing agreement. The filing does not provide specific financial guidance, outlook projections, or a detailed discussion of risks and contingencies beyond the nature of the new technology acquisition.
Investor Verification Checklist
- Verify the total cash consideration paid for the exclusive license.
- Confirm the specific royalty structure and percentage terms agreed upon.
- Assess the current stage of development for the stem cell expansion technology.
- Review the full text of the "Exclusive, World-Wide Patent and Technology License and Assignment Agreement" (Exhibit 10.1).